Product Images Vigabatrin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Vigabatrin NDC 59651-367 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure1 - vigabatrin fig1
The text is a description of a figure showing the percent reduction from baseline in seizure frequency. The figure includes a scale from 0 to 50 on the y-axis showing the percentage of patients, and four treatment groups on the x-axis: placebo, 1g/day vigabatrin, 30/day vigabatrin, and 6g/day vigabatrin. For each group, there are three bars representing the percentage of patients who experienced improvement, no change, or worsening of their seizures.*
Figure 2 - vigabatrin fig2
The text is describing a graph showing the percent reduction from baseline in seizure frequency for patients taking either a placebo or 3g/day of vigabatrin. The X-axis shows the percentage of patients, while the Y-axis shows the percent reduction in seizure frequency. The graph demonstrates a significant improvement in seizure frequency for patients taking 3g/day vigabatrin, with a decrease in seizure frequency of 50% or more for 100% of patients, whereas the placebo group showed no improvement.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg (100 Tablets Bottle) - vigabatrin fig3
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg (100 Tablets Carton Label) - vigabatrin fig4
str - vigabatrin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.